Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-06-16 @ 4:25 AM
Study NCT ID:
NCT01277302
Status:
COMPLETED
Last Update Posted:
2014-04-23
First Post:
2011-01-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FVF4967g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None